CLDN18.2=claudin 18 isoform. G/GEJ=gastric/gastroesophageal junction. IHC=immunohistochemistry.
CLDN18.2 reporting template
Download the guidance from our expert committee.
Global concordance study publication
Download the global concordance study publication, which assesses the performance and reproducability of three CLDN18.2 antibodies: 43-14A, EPR19202, and ZR451 in gastric cancer.
IHC assay guide
Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.
2024 Quality in pathology (QuIP) independent proficiency testing study
Click here to access the latest publication.
VENTANA CLDN18
(43-14A)
RxDx Assay performance
publication
2025
Download the publication, "Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples in SPOTLIGHT and GLOW."
eLearning center
Access a self-guided CLDN18.2 educational program.
